Long-term survival and clinical outcomes following direct-acting antiviral (DAA) treatment in HCV decompensated cirrhosis in Brazil: a real-world study

Long-term survival and clinical outcomes following direct-acting antiviral (DAA) treatment in HCV decompensated cirrhosis in Brazil: a real-world study

Introduction: The outcomes regarding portal hypertension-related complications and infections after HCV cure in decompensated cirrhosis are scarcely reported. We aimed to identify the predictors of survival and to evaluate the frequency of decompensation events of cirrhosis, including hepatocellular...

Full description

Bibliographic Details
Main Authors: Gustavo H. Pereira, Helena R. Peixoto, Mariana L. Giusti, Mariana L. Souza, Livia B. Victor, Flávia Fernandes, Renata M. Perez, Cristiane A. Villela-Nogueira
Format: Article
Language:English
Published: Elsevier 2022-09-01
Series:Brazilian Journal of Infectious Diseases
Subjects:
Direct-acting antiviral
Hepatitis C
Chronic
Liver cirrhosis
Sustained virologic response
Online Access:http://www.sciencedirect.com/science/article/pii/S1413867022003890

Internet

http://www.sciencedirect.com/science/article/pii/S1413867022003890

Similar Items